170 related articles for article (PubMed ID: 20448386)
1. TNM staging and classification (familial and nonfamilial) of breast cancer in Jordanian females.
Atoum MF; Hourani HM; Shoter A; Al-Raheem SN; Al Muhrib TK
Indian J Cancer; 2010; 47(2):194-8. PubMed ID: 20448386
[TBL] [Abstract][Full Text] [Related]
2. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
3. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer in Tunisia in 2004: a comparative clinical and epidemiological study.
Maalej M; Hentati D; Messai T; Kochbati L; El May A; Mrad K; Romdhane KB; Ben Abdallah M; Zouari B
Bull Cancer; 2008 Feb; 95(2):E5-9. PubMed ID: 18304901
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
6. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
7. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic analysis of the nipple-areolar complex occult involvement in early stage breast carcinoma].
Wang SY; Peng DF; Cai ZG; Zhang RZ; Yao TJ; Zhang H; Yang M; Dong HM
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):203-6. PubMed ID: 18756937
[TBL] [Abstract][Full Text] [Related]
9. Is pleomorphic lobular carcinoma really a distinct clinical entity?
Buchanan CL; Flynn LW; Murray MP; Darvishian F; Cranor ML; Fey JV; King TA; Tan LK; Sclafani LM
J Surg Oncol; 2008 Oct; 98(5):314-7. PubMed ID: 18668643
[TBL] [Abstract][Full Text] [Related]
10. [Breast cancer in the catchment area of the Graz Institute of Pathology. Evaluation of morphologic parameters based on 1,510 cases].
Hauser H; Beham A; Steindorfer P; Smola MG; Fruhwirth H; Klimpfinger M
Wien Klin Wochenschr; 1992; 104(23):717-20. PubMed ID: 1335634
[TBL] [Abstract][Full Text] [Related]
11. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
Classe JM; Loussouarn D; Campion L; Fiche M; Curtet C; Dravet F; Pioud R; Rousseau C; Resche I; Sagan C
Cancer; 2004 Mar; 100(5):935-41. PubMed ID: 14983488
[TBL] [Abstract][Full Text] [Related]
12. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation.
Hill-Kayser CE; Harris EE; Hwang WT; Solin LJ
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1313-9. PubMed ID: 16997501
[TBL] [Abstract][Full Text] [Related]
13. Contralateral breast cancer: factors associated with stage and size at presentation.
Mertens WC; Hilbert V; Makari-Judson G
Breast J; 2004; 10(4):304-12. PubMed ID: 15239788
[TBL] [Abstract][Full Text] [Related]
14. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
Bharat A; Gao F; Margenthaler JA
Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
[TBL] [Abstract][Full Text] [Related]
15. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Wilkie C; White L; Dupont E; Cantor A; Cox CE
Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920
[TBL] [Abstract][Full Text] [Related]
16. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
[TBL] [Abstract][Full Text] [Related]
17. TNM classification and breast cancer in an African population: a descriptive study.
Amir H; Azizi MR; Makwaya CK; Jessani S
Cent Afr J Med; 1997 Dec; 43(12):357-9. PubMed ID: 9631114
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
19. Incidental finding of mammary carcinoma in lumpectomy specimens.
Tang P; Hajdu SI; Conte CC; Filardi DA
Ann Clin Lab Sci; 2003; 33(1):23-31. PubMed ID: 12661895
[TBL] [Abstract][Full Text] [Related]
20. Solid-papillary carcinoma of the breast: clinicopathological study of 20 cases.
Otsuki Y; Yamada M; Shimizu S; Suwa K; Yoshida M; Tanioka F; Ogawa H; Nasuno H; Serizawa A; Kobayashi H
Pathol Int; 2007 Jul; 57(7):421-9. PubMed ID: 17587241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
